Sunit Mukherjee joined Symphony Technology Group in 2010 from Champlain Capital Partners. Sunit currently serves on the board of directors of ImpactRX.
Sunit’s prior experience includes working in the Mergers and Acquisitions group at Citigroup Investment Banking in New York, IL&FS Private Equity ($1.5B growth equity fund) in Mumbai and Deloitte Consulting in Atlanta, Georgia. Sunit’s industries of focus during his career include enterprise software, healthcare, and industrials. At Champlain, he has worked on financial transactions and strategic initiatives with several portfolio companies including CARSTAR, B27 LLC, Option One Home Medical, Freeman Beauty, Earth Tool Company and Bergensons Property Services. Sunit has a Bachelors from Indian Institute of Technology, Mumbai, a Masters from Georgia Institute of Technology in Atlanta and an MBA from the Harvard Business School.